Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Hematologic cancers in individuals infected by HIV

Antonino Carbone, Emanuela Vaccher, Annunziata Gloghini

Blood (2022) 139 (7): 995–1012.

https://doi.org/10.1182/blood.2020005469

Published: 2022

Journal Articles

Simultaneous occurrence of KSHV-associated malignancies in a patient affected by HIV

Emanuela Vaccher, Antonino Carbone

Blood (2021) 137 (22): 3149.

https://doi.org/10.1182/blood.2021011649

Published: 2021

Journal Articles

HAART Does Not Improve the Outcome of HIV-Related Multicentric Castleman Disease: Results of a Multicentric Retrospective Study

Chiara Cattaneo, Emanuela Vaccher, Alessandro Re, MD, Salvatore Casari, Erika Borlenghi, Michele Spina, MD, Umberto Tirelli, MD, Giuseppe Rossi

Blood (2011) 118 (21): 4918.

https://doi.org/10.1182/blood.V118.21.4918.4918

Published: 2011

Journal Articles

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (CDE) In Combination with HAART In HIV-Related Non-Hodgkin's Lymphomas (NHL)

Michele Spina, MD, Ulrich Jaeger, MD, Joseph A Sparano, Renato Talamini, Giuseppe Rossi, MD, Emanuela Vaccher, Umberto Tirelli

Blood (2010) 116 (21): 5072.

https://doi.org/10.1182/blood.V116.21.5072.5072

Published: 2010

Journal Articles

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

Michele Spina, MD, Jean Gabarre, MD, Salvatrice Mancuso, Alessandro Re, Clara Schiantarelli, Renato Talamini, Emanuela Vaccher, Umberto Tirelli

Blood (2010) 116 (21): 4827.

https://doi.org/10.1182/blood.V116.21.4827.4827

Published: 2010

Journal Articles

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

Alessandro Re, Mariagrazia Michieli, Salvatore Casari, Bernardino Allione, Chiara Cattaneo, Maurizio Rupolo, Michele Spina, Rosa Manuele, Emanuela Vaccher, Mario Mazzucato, Luciano Abbruzzese, Pierino Ferremi, Giampiero Carosi, Umberto Tirelli, Giuseppe Rossi

Blood (2009) 114 (7): 1306–1313.

https://doi.org/10.1182/blood-2009-02-202762

Published: 2009

Journal Articles

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (cde) in Combination with HAART in HIVRelated Non-Hodgkin’s Lymphomas (NHL).

Michele Spina, MD, Cecilia Simonelli, Emanuela Vaccher, Ulrich Jaeger, MD, Joseph Sparano, MD, Renato Talamini, Umberto Tirelli

Blood (2008) 112 (11): 1467.

https://doi.org/10.1182/blood.V112.11.1467.1467

Published: 2008

Journal Articles

AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy

Nicolas Mounier, Michele Spina, Jean Gabarre, Martine Raphael, Giuliano Rizzardini, Jean-Baptiste Golfier, Emanuela Vaccher, Antonino Carbone, Bertrand Coiffier, Guido Chichino, Andre Bosly, Umberto Tirelli, Christian Gisselbrecht, for the French-Italian cooperative group

Blood (2006) 107 (10): 3832–3840.

https://doi.org/10.1182/blood-2005-09-3600

Published: 2006

Journal Articles

HIV-Related Burkitt’s NHL (BL) vs. Diffuse Large-Cell NHL (DLCL) in the Pre- and HAART Eras: Significant Differences in Survival with Standard Chemotherapy.

Michele Spina, MD, Cecilia Simonelli, MD, Renato Talamini, ScD, Emanuela Vaccher, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 1436.

https://doi.org/10.1182/blood.V106.11.1436.1436

Published: 2005

Journal Articles

Hodgkin’s Disease and HIV Infection (HD-HIV) in Pre- and Post-HAART Era: The GICAT (Italian Cooperative Group on AIDS and Tumors) Experience in 139 Patients.

Umberto Tirelli, MD, Emanuela Vaccher, MD, Giuseppe Rossi, MD, Clara Schiantarelli, MD, Marco Fasan, MD, Michele Spina, MD

Blood (2005) 106 (11): 1437.

https://doi.org/10.1182/blood.V106.11.1437.1437

Published: 2005

Journal Articles

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Michele Spina, Ulrich Jaeger, Joseph A. Sparano, Renato Talamini, Cecilia Simonelli, Mariagrazia Michieli, Giuseppe Rossi, Ezio Nigra, Massimiliano Berretta, Chiara Cattaneo, Armin C. Rieger, Emanuela Vaccher, Umberto Tirelli

Blood (2005) 105 (5): 1891–1897.

https://doi.org/10.1182/blood-2004-08-3300

Published: 2005

Journal Articles

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection

Michele Spina, Jean Gabarre, Giuseppe Rossi, Marco Fasan, Clara Schiantarelli, Ezio Nigra, Maurizio Mena, Andrea Antinori, Adriana Ammassari, Renato Talamini, Emanuela Vaccher, Giampiero di Gennaro, Umberto Tirelli

Blood (2002) 100 (6): 1984–1988.

https://doi.org/10.1182/blood-2002-03-0989

Published: 2002

NARROW

Hematologic cancers in individuals infected by HIV

Simultaneous occurrence of KSHV-associated malignancies in a patient affected by HIV

HAART Does Not Improve the Outcome of HIV-Related Multicentric Castleman Disease: Results of a Multicentric Retrospective Study

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (CDE) In Combination with HAART In HIV-Related Non-Hodgkin's Lymphomas (NHL)

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (cde) in Combination with HAART in HIVRelated Non-Hodgkin’s Lymphomas (NHL).

AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy

HIV-Related Burkitt’s NHL (BL) vs. Diffuse Large-Cell NHL (DLCL) in the Pre- and HAART Eras: Significant Differences in Survival with Standard Chemotherapy.

Hodgkin’s Disease and HIV Infection (HD-HIV) in Pre- and Post-HAART Era: The GICAT (Italian Cooperative Group on AIDS and Tumors) Experience in 139 Patients.

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only